Chimeric antigen receptor T-cells: a review on current status and future directions for relapsed/refractory multiple myeloma
IS Hamadeh, R Friend, S Mailankody… - Frontiers in …, 2024 - pmc.ncbi.nlm.nih.gov
Although multiple myeloma is an incurable disease, the past decade has witnessed
significant improvement in patient outcomes. This was brought about by the development of …
significant improvement in patient outcomes. This was brought about by the development of …